DAS-181
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Name
- DAS-181
- Accession Number
- DB15313
- Description
DAS-181 is under investigation in clinical trial NCT00527865 (Single Dose Escalating Study of DAS181 in Adults).
- Type
- Biotech
- Groups
- Investigational
- Synonyms
- Farbefusp
- External IDs
- DAS181
Pharmacology
- Indication
- Not Available
- Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More- Pharmacodynamics
- Not Available
- Mechanism of action
- Not Available
- Absorption
- Not Available
- Volume of distribution
- Not Available
- Protein binding
- Not Available
- Metabolism
- Not Available
- Route of elimination
- Not Available
- Half-life
- Not Available
- Clearance
- Not Available
- Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More- Toxicity
- Not Available
- Affected organisms
- Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Classification
- Not classified
Chemical Identifiers
- UNII
- 227R1C272Q
- CAS number
- 946032-08-2
References
- General References
- Not Available
- External Links
- Not Available
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 3 Recruiting Treatment Coronavirus Disease 2019 (COVID‑19) / Immunocompromised / Lower Respiratory Tract Infection (LRTI) / Parainfluenza 1 2 Completed Treatment Flu caused by Influenza 2 2 Completed Treatment Parainfluenza 2 2 Not Yet Recruiting Treatment Coronavirus Disease 2019 (COVID‑19) / Influenza Infection / SAD-RV Infection and COVID-19 1 2 Withdrawn Treatment Parainfluenza Infections 1 2, 3 Withdrawn Treatment Coronavirus Disease 2019 (COVID‑19) 1 1 Completed Treatment Asthma / Bronchiectasis 1 1 Completed Treatment Flu caused by Influenza 3 1 Completed Treatment Healthy Volunteers 1 Not Available Completed Treatment Coronavirus Disease 2019 (COVID‑19) 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created on May 20, 2019 09:12 / Updated on July 03, 2020 11:52
Are you a data scientist
working on drug development?
DrugBank has a breadth of high quality data, organized and structured to support drug development research.